SCHEMBL7915938

SCHEMBL7915938

OCCCOB(O)c1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1138357 0.89 ALDH1A1 (0.31)
SCHEMBL5951665 0.77 DPP4 (0.39)
SCHEMBL1138361 0.76
Ethylene Glycol SCHEMBL27657993 0.71 MEN1 (0.34)
SCHEMBL1491911 0.71 PCSK9 (0.41)
SCHEMBL3665973 0.70
SCHEMBL11290456 0.68 PTPN1 (0.35)
SCHEMBL28354380 0.67 MMP1 (0.33)
SCHEMBL14983482 0.67 ALDH1A1 (0.40)
SCHEMBL526171 0.66 CES2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6221637-B1 IMMUNOMODULATORS FOR TREATING GRAFT REJECTION, OR NEPHRITIS; INHIBITS SIGNAL TRANSDUCTION BY T-CELLS; METHYL 2-(CARBOXYMETHYLSULFINYL)-5,7-DICHLORO-3,8-DIHYDROXY-6-METHYL-9-OXO-9H -XANTHENE-1-CARBOXYLATE, FOR EXAMPLE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-04-24 US disclosed
EP-0795554-A2 (Oxo-)xanthene derivatives, their preparation and their use as immunomodulators TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-09-17 EP disclosed